Boehringer Ingelheim Articles
Boeh Ingelheim & Abbott in US marketing deal
4 March 1999
BI granted a priority review for Aggrenox
4 March 1999
Telmisartan launched in the USA
24 February 1999
Boehringer Ingelheim appointment
11 February 1999
Scotia licenses satiety ingredient Olibra to General Mills
9 February 1999
Boehringer Ingelheim submits Mobic NDA - updated story
7 January 1999
Boehringer Ingelheim submits NDA for Mobic
21 December 1998
Stock Commentary Europe
10 December 1998
IFPMA Appointments
9 December 1998
Drug Majors Lose Competition Lawsuit
7 December 1998
Merger And Acquisition Prospects In Japan
7 December 1998
Stock Commentary Europe
3 December 1998
Boeh Ingelheim Pulls Out Of Foscan Deal With Scotia
27 November 1998
Optimism Over URT OTCs In Europe
24 November 1998
Telmisartan Becomes Sixth AIIRA To Be Registered
19 November 1998
Combivent Attack: Boeh Ingelheim Replies
5 November 1998
New Product Cycle For Glaxo Wellcome
28 October 1998
Shire Restarts Adderall Supplies
28 October 1998
Poor Rxing "Costs UK NHS L100 Mill/Year In England"
28 October 1998
Antisense '98 - The Key Players In R&D
22 October 1998
Tsuneki Kawabata promoted at Nippon Boehringer Ingelheim
22 October 1998
Scotia Narrows Losses, Foscan On Track
21 October 1998
World Pharma Market Sales Leaders
6 October 1998
First Approval Of DuPont's Sustiva In USA
21 September 1998
D&TB Revisits Aricept; Remains "Unconvinced"
10 September 1998
Interneuron Settles Redux Lawsuits For $70 Million
8 September 1998
Atrovent Now For Pediatric Use
3 September 1998
Shire Pharmaceuticals Arrange ADD Drug Ingredients Supply
3 September 1998
Euro HIV/AIDS Market Competition
2 September 1998
Progress For Shire On Restarting ADHD Supplies
1 September 1998
IVAX, Immunex File For Generic Taxol In USA
18 August 1998
German Remedies To Invest In Other Indian Entities
7 August 1998
Many US Companies Go Into The Black For 2nd Qtr
5 August 1998
W-L's Lipitor "Will Be World Top-Seller In 2005"
3 August 1998
Genentech Pulls t-PA Stroke Study
22 July 1998
Cerestat Link Dissolved
16 July 1998
ECASS II: More Bad News For Thrombolysis In Stroke
16 July 1998
Abbott Labs Impacted By Strength Of Dollar
14 July 1998
Agouron Shopping For HIV Portfolio
1 July 1998
Mirapex May Help PD Tremor, Say New Data
18 June 1998
Pharma Industry Visions And Proposals
15 June 1998
Dramatic Growth Seen In Europe's Biotech Sector
4 June 1998
Boeh Ingelheim Unveils Strong Product Pipeline
19 May 1998
Horrobin Severs Scotia Links After Restructuring
14 May 1998
Horrobin Severs Scotia Links After Restructuring
12 May 1998
Procysteine Study Halted And Unblinded
11 May 1998
Name Change For Windsor Healthcare
6 May 1998
$360M Pharma Investment In China's Pudong Region
17 April 1998
Viramune Launched In The UK For HIV
15 April 1998
BI To Redevelop UK Office
2 April 1998
Management Changes At BI UK
2 April 1998
Rhone-Poulenc Rorer Slipping In Asthma Market
1 April 1998
Italian Self-Med Sector Wants Clear Euro Market Rules
31 March 1998
Anti-Infective News In Brief
19 March 1998
GW Makes Foray Into Cardiovascular Arena
18 March 1998
Cambridge NeuroScience To Further Analyse Cerestat Data
12 March 1998
Procysteine Trial In ARDS On Track
12 March 1998
Scotia Quietly Confident About Product Pipeline
5 March 1998
Pramipexole Approved In The European Union
5 March 1998
Biotech Promise For Rheumatoid Arthritis
26 February 1998
R-PR Dominates Patent Activity In Gene Therapy
19 February 1998
Consolidation In European Pharma
17 February 1998
SS Pharma/Boeh Ing Marketing Deal
16 February 1998
Boeh Ingelheim Signs Drug-Delivery Deal
13 February 1998
A Real Challenge To HIV With New Therapies?
12 February 1998
US Corporate 1997 Year-End Results Round-Up
11 February 1998
Indian Drug Co Looks For Merger Boost
5 February 1998
Greece To Slim Official Drug List
4 February 1998
Yamanouchi Looks For Gaster Successor
22 January 1998
SS Pharma To Market Boehringer Ingelheim OTCs In Japan
21 January 1998
Boeh Ing Abandons Cerestat Trial
18 December 1997
Boeh Ing KG Regroups With Karl Thomae
18 December 1997
Boehringer Ingelheim Completes Ben Venue Acquisition
11 December 1997
Oncology Update In Brief
8 December 1997
FDA Panel Backs Novo's Repaglinide
27 November 1997
German Remedies Expands In India
14 November 1997
Axys : The Shape Of Things To Come For Biotech ?
5 November 1997
Can Protease Inhibitor Resistance Be Combatted?
4 November 1997
Pramipexole Approved By The EMEA
23 October 1997
NP And Reckitt Confirm Indian OTC Deal
21 October 1997
Greece: Industry Fury At Govt Price Moves
20 October 1997
Roche's Invirase Confers Survival Benefit
20 October 1997
Yamanouchi's Flomax Launched In USA
16 October 1997
NDA Filed For New Soft-Gel Saquinavir
9 October 1997
Boehringer Ingelheim's BIRR 4 Cold Therapy
9 October 1997
Boehringer Ingelheim Opens New R&D Center In Canada
30 September 1997
Cambridge Stops Cerestat Trial In Brain Injury
25 September 1997
Mirapex Cuts Levodopa Reliance
25 September 1997
Corporate News In Brief
24 September 1997
Growing Foreign Presence In China's Pharma Industry
22 September 1997
Scotia Sells Rights To Foscan For $54m
17 September 1997
Appointment At Boehringer Ingelheim UK
11 September 1997
Novo's Repaglinide To Be Fast-Tracked In USA
4 September 1997
UK Industry Code Of Practice Report
1 September 1997
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
